The study shows that icaritin-induced mitophagy through PINK1/Parkin actually helps HCC cells survive, contradicting the typical view that mitophagy eliminates damaged cells. This counterintuitive finding suggests mitophagy may serve as a protective mechanism in cancer contexts, but the underlying molecular basis remains unexplained. Gap type: contradiction Source paper: Icaritin with autophagy/mitophagy inhibitors synergistically enhances anticancer efficacy and apoptotic effects through PINK1/Parkin-mediated mitophagy in hepatocellular carcinoma. (2024, Cancer letters, PMID:38242198)
Landscape Summary: How does PINK1/Parkin-mediated mitophagy paradoxically promote cancer cell survival in HCC? is a 0.8 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
How does PINK1/Parkin-mediated mitophagy paradoxically promote cancer cell survival in HCC? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: